Anti-TNF-alpha antibody therapies in autoimmune diseases.
about
Critical role of MARCO in crystalline silica-induced pulmonary inflammationTNFalpha: a trigger of autonomic dysfunctionStructure-based repurposing of FDA-approved drugs as TNF-α inhibitors.Effect of solar particle event radiation on gastrointestinal tract bacterial translocation and immune activationCytokines in common variable immunodeficiency as signs of immune dysregulation and potential therapeutic targets - a review of the current knowledge.Biologics that inhibit the Th17 pathway and related cytokines to treat inflammatory disorders.Drugs for Autoimmune Inflammatory Diseases: From Small Molecule Compounds to Anti-TNF Biologics.Fullerenes and their derivatives as inhibitors of tumor necrosis factor-α with highly promoted affinities.Immunomodulatory Nanomedicine.Structure-based discovery of natural-product-like TNF-α inhibitors.Current therapeutic leads for the treatment of autoimmune diseases: stem cell transplantation and inhibition of post-translational modifications of autoantigens.A metal-based inhibitor of tumor necrosis factor-α.Gold-Catalyzed Cycloisomerization and Diels-Alder Reaction of 1,4,9-Dienyne Esters to 3 a,6-Methanoisoindole Esters with Pro-Inflammatory Cytokine Antagonist Activity.SERS-based monitoring of the intracellular pH in endothelial cells: the influence of the extracellular environment and tumour necrosis factor-α.Novel insights into neuroinflammation: bacterial lipopolysaccharide, tumor necrosis factor α, and Ureaplasma species differentially modulate atypical chemokine receptor 3 responses in human brain microvascular endothelial cells.Emerging Roles of Vascular Cell Adhesion Molecule-1 (VCAM-1) in Immunological Disorders and Cancer.
P2860
Q28388164-4C9112B0-0EB1-4CF0-8B7F-03AB2632A6D7Q33155571-635D7FC4-45C2-4247-8376-18C7BD1A8A72Q33834499-A492AA2D-660A-4EF3-8F7A-555CB5E4877EQ36611317-0EA33272-A17B-4CF8-9438-F69360DEEDDBQ38211700-B116E637-C7AD-4028-AB47-0B7D2290CA2BQ38632657-09A8456B-AE50-41FB-B32C-ED2EEA8901FFQ38645738-3E82CADA-AC6F-4AF2-94AB-6B23540CE158Q38851521-2F3EF3A7-11A9-4230-A525-3AB435813128Q39224331-F7A8D557-A867-4BEF-BE2E-8EDDDDF2261AQ41847456-30469931-020D-4C00-9D38-419E38340351Q45263742-B3FE99B3-2D70-44C1-B131-607B711B23F9Q50243911-F8D663EA-042C-492C-9E78-F5A4EDD5C3B2Q50912687-5CB25513-82F9-4835-8F61-0B803F471500Q53673813-B65D92F4-304D-43EB-BA1F-FBD2E4B9B706Q54942011-CECB74AD-9479-4478-8655-EABDB7070CE7Q55012033-59D17FDF-0A61-44D7-AEA3-2561BB962724
P2860
Anti-TNF-alpha antibody therapies in autoimmune diseases.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Anti-TNF-alpha antibody therapies in autoimmune diseases.
@ast
Anti-TNF-alpha antibody therapies in autoimmune diseases.
@en
type
label
Anti-TNF-alpha antibody therapies in autoimmune diseases.
@ast
Anti-TNF-alpha antibody therapies in autoimmune diseases.
@en
prefLabel
Anti-TNF-alpha antibody therapies in autoimmune diseases.
@ast
Anti-TNF-alpha antibody therapies in autoimmune diseases.
@en
P1476
Anti-TNF-alpha antibody therapies in autoimmune diseases.
@en
P2093
Athanasia Mouzaki
Kokona Chatzantoni
P304
P356
10.2174/156802606778194217
P577
2006-01-01T00:00:00Z